This aligned with the findings from previous research in which the expression of p-ERK1/2/ ERK1/2 and p-P65/P65 was alleviated and lung fibrosis was attenuated (Yao et al., 2021). This evidence concerns the gene MAPK3 and pulmonary fibrosis.